Monica L. Guzman, Ph.D.
Affiliations: | 2002 | University of Kentucky, Lexington, KY |
Area:
Molecular BiologyGoogle:
"Monica Guzman"Parents
Sign in to add mentor| Brett T. Spear | grad student | 2002 | University of Kentucky | |
| (Unique molecular differences between acute myelogenous leukemia and normal hematopoietic stem cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Di Meo F, Iyer A, Akama K, et al. (2023) A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma. Cell Reports. Medicine. 4: 101110 |
| Sugita M, Yamazaki T, Alhomoud M, et al. (2023) Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia. Cell Death & Disease. 14: 305 |
| Pemmaraju N, Kantarjian HM, Sweet KL, et al. (2022) North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need. Blood |
| Sugita M, Galetto R, Zong H, et al. (2022) Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia. Nature Communications. 13: 2227 |
| Cai T, Gouble A, Black KL, et al. (2022) Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells. Nature Communications. 13: 2228 |
| Balandrán JC, Dávila-Velderrain J, Sandoval-Cabrera A, et al. (2021) Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL. Frontiers in Immunology. 12: 746492 |
| Sugita M, Wilkes DC, Bareja R, et al. (2021) Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia. Npj Precision Oncology. 5: 44 |
| Kawabata KC, Zong H, Meydan C, et al. (2020) BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells. Blood |
| Merugu S, Sharma S, Kaner J, et al. (2020) Chemical probes and methods for single-cell detection and quantification of epichaperomes in hematologic malignancies. Methods in Enzymology. 639: 289-311 |
| Sugita M, Guzman ML. (2020) CD123 as a Therapeutic Target Against Malignant Stem Cells. Hematology/Oncology Clinics of North America. 34: 553-564 |